DexCom Inc (DXCM) Stock Analysis
DexCom Inc trades on the NASDAQ under the ticker DXCM. StonkBuddy files it under Healthcare. It is in the S&P 500.
DXCM price context
- 52-week range: $54.11 to $92.59 (as of October 23, 2026)
- Market value: about $32.45 billion (October 19, 2026)
Next earnings
DexCom Inc is expected to report results on October 29, 2026, after the market closes. Earnings calendar
Congress trades in DXCM
In the last 12 months, members of Congress reported 3 trades in DXCM (House and Senate disclosure reports). The latest reported:
- Tina Smith: Sold, $100,001 - $250,000, traded May 7, 2026, reported May 10, 2026 (filing)
- Tina Smith: Sold part, $100,001 - $250,000, traded April 29, 2026, reported May 10, 2026 (filing)
- John Boozman: Bought, $1,001 - $15,000, traded January 26, 2026, reported February 15, 2026 (filing)
- Robert P. Bresnahan, Jr.: Bought, $1,001 - $15,000, traded May 15, 2025, reported June 9, 2025 (filing)
- Jefferson Shreve: Sold, $15,001 - $50,000, traded May 12, 2025, reported June 22, 2025 (filing)
All Congress trades · Filed this week
Insider trades in DXCM
Since September 30, 2026, DexCom Inc's officers, directors and large owners have filed 2 open-market buys and sales of its shares (SEC Form 4). The latest reported:
- Michael Jon Brown, EVP Chief Legal Compliance Off, sold 1,700 shares at $85.48 on October 15, 2026, reported October 19, 2026 (Form 4)
- Sadie Stern, EVP Chief People & Culture Off, sold 2,565 shares at $86.15 on September 28, 2026, reported September 30, 2026 (Form 4)
Members also see the StonkBuddy score for DXCM on this page. What the score means